GNTW yields 66.67% · PFE yields 6.13%● Live data
📍 GNTW pulled ahead of the other in Year 1
Combined, GNTW + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GNTW + PFE for your $10,000?
Stemtech Corporation, a stem cell nutrition company, develops and sells various dietary supplements. It offers stemrelease3, a stem cell enhancer, which supports the body's natural renewal system, a general sense of wellbeing, and telomeres health, as well as promotes youthful and healthy aging; StemFlo that supports optimal blood and healthy stem cell flow, protect the cardiovascular system from oxidative damage, boosts vitality, and promotes healthy aging; and MigraStem, a natural source of potent antioxidants, phytonutrients, fiber, and polysaccharides, which optimizes the migration of stem cells, enhance the immune system performance, support detoxification and anti-oxidative functions, enhances healthy longevity, and provide vitality and well-being. The company also provides OraStem that protects, strengthens, rejuvenates, restores, and supports teeth and gum function from the cellular level, as well as offer anti-oxidative and anti-microbial protection, supports tooth strength with essential minerals, helps to remove stains, brightens teeth in a natural and non-abrasive way, and freshens breath; and D-Fuze, an electromagnetic frequency (EMF) filter that protects the body from potential harm by dispersing EMFs to lower the specific absorption rate. It serves customers in Australia, Canada, Ecuador, Malaysia, Mexico, Namibia, New Zealand, the Philippines, Singapore, South Africa, Taiwan, Togo, and the United States. The company was founded in 2005 and is based in Miramar, Florida.
Full GNTW Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.